BRSK1 Gene

title: BRSK1 Gene

BRSK1 (Brain-Specific Serine/Threonine-Protein Kinase 1)

Overview

BRSK1 is a brain-enriched serine/threonine kinase essential for neuronal polarization and axon specification. It phosphorylates [tau](/proteins/tau) and other microtubule-associated proteins, linking cytoskeletal regulation to neuronal development and [neurodegenerative disease](/diseases/neurodegeneration). [@inoue2006]

<div class="infobox infobox-gene"> [@mller2010]

| Property | Value | [@ando2016]
|----------|-------| [@lu2013]
| Gene Symbol | BRSK1 |
| Full Name | Brain-Specific Serine/Threonine-Protein Kinase 1 |
| Aliases | SAD-B, SADB, brain-selective kinase 1 |
| Chromosomal Location | 19q13.42 |
| NCBI Gene ID | [84446](https://www.ncbi.nlm.nih.gov/gene/84446) |
| OMIM ID | [609235](https://omim.org/entry/609235) |
| Ensembl ID | [ENSG00000160469](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000160469) |
| UniProt ID | [Q8TDC3](https://www.uniprot.org/uniprot/Q8TDC3) |
| Encoded Protein | [BRSK1 Protein](/proteins/brsk1-protein) |
| Associated Diseases | Alzheimer's disease, tauopathies, neurodevelopmental disorders |

</div>

Introduction

...

title: BRSK1 Gene

BRSK1 (Brain-Specific Serine/Threonine-Protein Kinase 1)

Overview

BRSK1 is a brain-enriched serine/threonine kinase essential for neuronal polarization and axon specification. It phosphorylates [tau](/proteins/tau) and other microtubule-associated proteins, linking cytoskeletal regulation to neuronal development and [neurodegenerative disease](/diseases/neurodegeneration). [@inoue2006]

<div class="infobox infobox-gene"> [@mller2010]

| Property | Value | [@ando2016]
|----------|-------| [@lu2013]
| Gene Symbol | BRSK1 |
| Full Name | Brain-Specific Serine/Threonine-Protein Kinase 1 |
| Aliases | SAD-B, SADB, brain-selective kinase 1 |
| Chromosomal Location | 19q13.42 |
| NCBI Gene ID | [84446](https://www.ncbi.nlm.nih.gov/gene/84446) |
| OMIM ID | [609235](https://omim.org/entry/609235) |
| Ensembl ID | [ENSG00000160469](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000160469) |
| UniProt ID | [Q8TDC3](https://www.uniprot.org/uniprot/Q8TDC3) |
| Encoded Protein | [BRSK1 Protein](/proteins/brsk1-protein) |
| Associated Diseases | Alzheimer's disease, tauopathies, neurodevelopmental disorders |

</div>

Introduction

BRSK1 (Brain-Specific Serine/Threonine-Protein Kinase 1), also known as SAD-B (synapses of amphids defective), is a member of the AMPK-related kinase family. It was first identified in C. elegans as a kinase required for presynaptic vesicle clustering and subsequently shown to be critical for mammalian neuronal polarization. BRSK1 and its paralog [BRSK2](/genes/brsk2) are among the most brain-enriched kinases in the mammalian genome, and their combined activity is essential for axon-dendrite specification during cortical development. BRSK1 phosphorylates tau at KXGS motifs and regulates microtubule dynamics, placing it at the intersection of normal neuronal development and neurodegenerative tau pathology.

Function

Neuronal Polarization and Axon Specification

BRSK1 is one of the master regulators of neuronal polarity:

• Axon determination — BRSK1 is activated by [LKB1/STK11](/genes/stk11) at the nascent axon tip; its local activation triggers the symmetry-breaking event that converts one neurite into the axon
• SAD kinase function — In C. elegans, the SAD-1 ortholog clusters synaptic vesicles at presynaptic terminals; mammalian BRSK1 retains this function while gaining additional polarity roles
• Double knockout phenotype — BRSK1/BRSK2 double knockout mice fail to develop axons entirely, demonstrating the essential nature of these kinases for neuronal polarization
• Microtubule reorganization — BRSK1 phosphorylates MAPs to promote the transition from mixed to uniformly plus-end-out microtubule polarity in the nascent axon
• Axon initial segment — BRSK1 contributes to establishing the axon initial segment (AIS), the specialized domain that separates axonal from somatodendritic compartments

Tau Phosphorylation

BRSK1 is a physiologically relevant tau kinase:

• KXGS motif phosphorylation — Phosphorylates tau at Ser262 and Ser356 within microtubule-binding repeats, similar to [MARK kinases](/genes/mark4)
• Microtubule detachment — BRSK1-mediated tau phosphorylation reduces tau-microtubule affinity, creating dynamic microtubule regions necessary for axon growth
• Developmental timing — BRSK1 tau phosphorylation is highest during embryonic neuronal development (E13-E18), then decreases postnatally as stable microtubule arrays form
• Cooperative phosphorylation — BRSK1 can prime tau for subsequent phosphorylation by [GSK3β](/genes/gsk3b) and [CDK5](/genes/cdk5)

Presynaptic Vesicle Regulation

BRSK1 regulates presynaptic function:

• Vesicle clustering — Phosphorylates substrates at presynaptic terminals that organize synaptic vesicle pools
• Active zone organization — Contributes to the spatial organization of neurotransmitter release sites
• Synaptic transmission — BRSK1 deficiency leads to impaired synaptic vesicle cycling and reduced neurotransmitter release

Regulation

• LKB1 activation — The primary activating kinase; [LKB1](/genes/stk11) phosphorylates BRSK1 at Thr189 in the activation loop
• 14-3-3 binding — Phosphorylated BRSK1 associates with 14-3-3 proteins, which modulate its subcellular localization
• Calcium regulation — BRSK1 activity may be modulated by calcium-dependent signaling in [neurons](/entities/neurons)
• Lipid binding — The C-terminal UBA domain and kinase-associated domain contribute to membrane targeting

Disease Associations

Alzheimer's Disease

BRSK1 is implicated in AD through tau-dependent mechanisms:

• Tau hyperphosphorylation — Aberrant reactivation of BRSK1 in mature neurons may contribute to pathological tau phosphorylation at Ser262, one of the earliest modified sites in AD
• Developmental kinase reactivation — The "developmental recapitulation" hypothesis proposes that kinases normally active during embryonic neuronal polarization (including BRSK1) become reactivated in AD, driving tau pathology
• Expression changes — BRSK1 expression and activity are altered in AD brain tissue, particularly in hippocampal and entorhinal cortical neurons
• Synapse loss — BRSK1 dysregulation may contribute to presynaptic dysfunction and synapse loss, a hallmark correlate of cognitive decline in AD

Tauopathies

• Progressive supranuclear palsy — BRSK1 may contribute to 4R-tau pathology characteristic of [PSP](/diseases/progressive-supranuclear-palsy)
• Corticobasal degeneration — Elevated BRSK activity has been reported in CBD brain tissue
• [MAPT](/proteins/tau) mutations — FTD-causing [MAPT](/genes/mapt) mutations may alter tau's susceptibility to BRSK1 phosphorylation

Neurodevelopmental Disorders

• Cortical malformations — Given BRSK1's essential role in neuronal polarization, loss-of-function variants may cause cortical development defects
• Intellectual disability — Rare variants in BRSK1 have been identified in cases of intellectual disability with structural brain abnormalities
• Autism spectrum disorder — BRSK1 is expressed in brain regions affected in ASD, and polarity defects may contribute to cortical connectivity abnormalities

Structural Features

BRSK1 contains several functional domains essential for its kinase activity[@chen2014][@yokota2010]:

Kinase Domain

• Catalytic core: Contains the active site for ATP binding and phosphoryl transfer
• Activation loop: Thr189 phosphorylation by LKB1 is required for activity
• Substrate recognition: Specific residues recognize tau and other MAPs

Regulatory Domains

• UBA domain: Ubiquitin-associated domain at C-terminus
• KA1 domain: Kinase-associated domain involved in membrane targeting
• Helical linker: Connects kinase domain to regulatory regions

Therapeutic Implications

Kinase Inhibitor Development

Targeting BRSK1 therapeutically requires understanding its dual role:

| Approach | Strategy | Challenge |
|-----------|----------|-----------|
| Inhibition | Block pathological tau phosphorylation | May disrupt neuronal development |
| Activation | Enhance protective signaling | Need cell-type specificity |
| Modulation | Fine-tune activity levels | Therapeutic window |

Biomarker Potential

BRSK1 as a biomarker:

• Activity markers: Phospho-Thr189 levels indicate activation status
• Expression changes: Altered levels in AD brain tissue
• Genetic variants: Disease-associated polymorphisms

Research Methods

Molecular Biology Approaches

• CRISPR knockout: Studying loss-of-function phenotypes
• Phospho-antibodies: Detecting specific phosphorylation sites
• Kinase assays: Measuring catalytic activity

Cellular Models

• Primary neurons: Primary cortical neuron cultures
• iPSC-derived neurons: Disease modeling potential
• Organoid systems: Three-dimensional brain models

Animal Models

• Knockout mice: BRSK1/BRSK2 double knockout
• Conditional knockouts: Cell-type-specific deletion
• Behavioral analysis: Cognitive and motor function

Expression

BRSK1 has highly brain-enriched expression:

• Brain regions — Strongly expressed in [hippocampus](/brain-regions/hippocampus), cerebral [cortex](/brain-regions/cortex), cerebellum, and olfactory bulb; lower expression in brainstem and spinal cord
• Cell types — Predominantly neuronal; minimal expression in [astrocytes](/cell-types/astrocytes) or [microglia](/cell-types/microglia)
• Developmental expression — Peaks during embryonic cortical neurogenesis (E13-E18 in mouse); maintained at lower levels in adult brain
• Subcellular localization — Axonal growth cones during development; presynaptic terminals in mature neurons
• Tissue specificity — Among the most brain-specific kinases; very low expression in non-neural tissues
• Allen Brain Atlas — [BRSK1 expression data](https://portal.brain-map.org/)

See Also

• [BRSK1 Protein](/proteins/tau)
• [neurodegenerative disease](/diseases/neurodegeneration)
• [PSP](/diseases/progressive-supranuclear-palsy)

External Links

• [NCBI Gene: BRSK1](https://www.ncbi.nlm.nih.gov/gene/84446)
• [Ensembl: ENSG00000160469](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000160469)
• [UniProt: Q8TDC3](https://www.uniprot.org/uniprot/Q8TDC3)
• [GeneCards: BRSK1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=BRSK1)
• [OMIM: BRSK1](https://omim.org/search?search=BRSK1)
• [Allen Brain Atlas: BRSK1](https://human.brain-map.org/microarray/search/show?search_term=BRSK1)

Cross-links

• [BRSK1 Protein — Encoded protein](/genes/brsk1)
• [BRSK2 Gene — Paralog, redundant functions in neuronal polarity](/genes/ar)
• [LKB1/STK11 Gene — Upstream activating kinase](/proteins/stk11)
• [Tau Protein — Key substrate](/proteins/tau)
• [MAPT Gene — Encodes tau](/genes/des)
• [MARK2 Gene — Related AMPK-family tau kinase](/genes/ar)
• [MARK4 Gene — Related AMPK-family tau kinase](/genes/ar)
• [CDK5 Gene — Cooperating tau kinase](/genes/cdk5)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• Microtubule Dynamics

References

[Kishi et al., Mammalian SAD kinases are required for neuronal polarization (2005) (2005)](https://doi.org/10.1126/science.1107403)

[Barnes et al., LKB1 and SAD kinases define a pathway required for the polarization of cortical neurons (2007) (2007)](https://doi.org/10.1016/j.cell.2007.01.025)

[Crump et al., The SAD-1 kinase regulates presynaptic vesicle clustering and axon termination (2001) (2001)](https://doi.org/10.1016/S0896-6273(01)

[Inoue et al., SAD: A presynaptic kinase associated with synaptic vesicles and the active zone cytomatrix (2006) (2006)](https://doi.org/10.1523/JNEUROSCI.4332-05.2006)

[Müller et al., Regulation of MARK/PAR-1 family kinases by LKB1 in neuronal polarity (2010) (2010)](https://doi.org/10.1073/pnas.1003498107)

[Ando et al., Stabilization of microtubule-unbound tau via tau phosphorylation at Ser262/356 by Par-1/MARK contributes to tau toxicity in vivo (2016) (2016)](https://doi.org/10.1371/journal.pgen.1005917)

[Lu et al., Initial neurite outgrowth in Drosophila neurons is driven by Kinesin-powered microtubule sliding (2013) (2013)](https://doi.org/10.1083/jcb.201302077)

[Shelly et al., LKB1 and SAD kinases in neuronal polarity and axon formation (2007)](https://doi.org/10.1016/j.neuron.2007.02.019)

[Barnes et al., Par-1/MARK kinases and tau phosphorylation in Alzheimer's disease (2010)](https://doi.org/10.1007/s00439-010-0820-7)

[Chen et al., SAD kinase family in neurodevelopment and disease (2014)](https://doi.org/10.1016/j.neuroscience.2014.09.056)

[Yokota et al., Regulation of neuronal polarity by LKB1 and SAD kinases (2010)](https://doi.org/10.1007/s00439-010-0841-2)

[Farzan et al., Tau phosphorylation by SAD kinases in health and disease (2019)](https://doi.org/10.1111/jnc.14698)

[Wang et al., SAD kinases in synaptic development and function (2018)](https://doi.org/10.1016/j.brainres.2018.02.021